在受控释放应用中对刺激响应桥梁聚二素的审查和未来前景
Xin Zhang1, Han Zhang2, Xiaonan Liu1
1Shandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmaceutical Research, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Polymers
|November 27, 2024
概括
刺激响应的桥接聚二素 (BPS) 提供可调节的,生物相容的平台,用于控制药物输送. 本综述详细介绍了它们的合成,特性和促进生物医学研究的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
背景情况:
- 桥梁聚二氧化 (BPS) 是有机-无机生物材料的混合物.
- 它们表现出有利的特性,如生物相容性,可调性特性和设计灵活性.
- 作为治疗和诊断应用的载体,BPS正在被探索.
研究的目的:
- 提供对刺激响应BPS的全面概述.
- 专注于合成策略,生物相容性和生物降解性.
- 评估控制释放能力,以应对特定的刺激.
主要方法:
- 对刺激响应性BPSs现有文献的审查.
- 合成方法和材料属性的分析.
- 控制释放机制和应用的批判性评估.
主要成果:
- 响应刺激的BPS能够准确有效地控制治疗药物的释放.
- 这些材料提供了一个安全的平台,由内源和外源刺激激活.
- BPS显示出各种生物医学应用的巨大潜力.
结论:
- 响应刺激的BPS是有希望的先进生物材料,用于向药物输送.
- 对它们的设计和开发进行进一步的研究可以大大推进生物医学研究.
- 这些材料在开发下一代治疗系统方面发挥着至关重要的作用.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Modified-Release Drug Delivery Systems: Influencing Factors
216
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
216
Modified-Release Drug Delivery Systems: Classification
320
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
320
Modified-Release Drug Delivery Systems: Rate-Programmed I
175
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
175
Modified-Release Drug Delivery Systems: Stimuli-Activated
186
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
186
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167


